1. Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy. Issue 3 (September 2015) Authors: Kossai, M.; Duchemann, B.; Boutros, C.; Caramella, C.; Hollebecque, A.; Angevin, E.; Gazzah, A.; Bahleda, R.; Ileana, E.; Massard, C.; Vielh, P.; Soria, J.C.; Besse, B. Journal: Lung cancer Issue: Volume 89:Issue 3(2015:Sep.) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-014: Molecular screening for cancer treatment optimization in head and neck cancer (MOSCATO 01). (February 2015) Authors: Even, C.; Breuskin, I.; Ileana, E.; Massard, C.; Lacroix, L.; Lezghed, N.; Guigay, J.; Janot, F.; Soria, J.C.; Ferté, C. Journal: Radiotherapy and oncology Issue: Volume 114(2015:Jan.)Supplement 1 Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours. (August 2017) Authors: Hollebecque, A.; Bahleda, R.; Faivre, L.; Adam, J.; Poinsignon, V.; Paci, A.; Gomez-Roca, C.; Thery, J.C.; Le Deley, M.C.; Varga, A.; Gazzah, A.; Ileana, E.; Gharib, M.; Angevin, E.; Malekzadeh, K.; Massard, C.; Soria, J.C.; Spano, J.P. Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗